The former CEO and President of Eli Lilly offers thoughts on changing the game against cancer in a Wall Street Journal op-ed article. The...

IARC and the UN deem February 4 World Cancer Day. Therefore, some statistics on the rampant growth of cancer. As in the past, everyone is...

And so a new year arrives, with new opportunities. For lawyers interested in new pro bono advocacy for 2014, how about assisting persons...

Christmas Day – a time for peace, joy, love and hope. Imagine, however, how the day feels if you are a parent, sibling or friend of James...

Tis the season for donating to mesothelioma research, and obtaining a 2 for 1 match on your contribution, until year end. Where? At MARF...

(The picture above shows one of two halls used for poster sessions at ASH 2013. The picture is courtesy of Pieter Droppert, who writes...

One part of change is creating great new scientific findings and related products. Another part relates to adoption and translation into...

A new case report may be of interest for asbestos lawyers. The report is online in full at no cost. The abstract is pasted below....

Quest is out with news that it will sell a BRACA gene patent test for 40% less than Myriad’s BRACA gene patent test. Meanwhile, Mryiad...

Epigenetic changes and cancer continue to tie together. A new example arises from CEBPA. It’s a gene. The purpose of CEBPA is to cause...

A reminder of a point stressed during June’s Perrin conference on asbestos science. There, the experts stressed the fact that gene...

A new, peer-reviewed article in Cancer (paywall) proffers evidence suggesting material increased risks of non-Hodgkin lymphoma in persons...

Kevin Noonan of Patent Docs has provided an expert, cogent summary of Myriad’s arguments to enjoin some other providers of testing for...

In toxic torts, we meet way too many people with terminal cancer. They end facing barrages of objective questions about past exposure,...

Myriad has filed yet another patent infringement suit against BRCA gene sequencers. Patent Docs once again provides the specifics. #Cancer

The Myriad decision was supposed to end Myriad’s stranglehold on testing for mutations of BRACA genes. The patent was illegal because...

Lawyers litigating lung cancer cases will need increasing knowledge of mutations related to lung cancer, and their implications as to...

PBS, Ken Burns and Katie Couric are collaborating to bring cancer’s biography to television in a six hour mini-series. The series will...

New phases of cancer treatment are arriving, and have the attention of doctors, patients, the FDA and Wall Street. Trial lawyers, risk...

It’s always good to listen to experts; sometimes the message also will be accurate. In the late 2000s, I chaired an international...